Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ProNAi nabs $59.5M round to back PhII lymphoma drug
Fierce Biotech
Tuesday, April 22, 2014 - 10:02am
tags:
ProNai, PNT2258, lymphoma
With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies
Forbes
Tuesday, April 22, 2014 - 9:51am
tags:
Novartis, M&A, GSK, Eli Lilly, Allergan, Valeant Pharmaceuticals
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
Yahoo
Tuesday, April 22, 2014 - 9:47am
tags:
hepatitis C, FDA, Enanta Pharmaceuticals, ABT-450, AbbVie
Ulthera registers for $86M IPO
Mass Device
Tuesday, April 22, 2014 - 9:44am
tags:
IPOs, devices, Ulthera, ultrasound
[video] Novartis Deal Accretive From Day One, Witty Says
Bloomberg
Tuesday, April 22, 2014 - 9:43am
tags:
Novartis, Andrew Witty, GSK, M&A
What to Watch for in Biotech Earnings This Week
Motley Fool
Tuesday, April 22, 2014 - 9:33am
tags:
biotech, earnings, Gilead Sciences, Celgene, Amgen, BiogenIdec
Neuralstem's Cell Therapy Is Working, And This Is Just The Beginning
Seeking Alpha
Tuesday, April 22, 2014 - 9:31am
tags:
Neuralstem, cell therapy, NSI-566
The price is right for patient-switching on Biogen's new hemophilia med Alprolix
Fierce Pharma
Tuesday, April 22, 2014 - 9:30am
tags:
Biogen Idec, hemophilia B, drug pricing, Alprolix
Report: Biopharma CEOs score 'supersalaries' even as sales decline
Fierce Pharma
Tuesday, April 22, 2014 - 9:29am
tags:
executive pay, Pharma CEOs
[video] Novartis CEO Says New Purchases Will Boost Sales
Bloomberg
Tuesday, April 22, 2014 - 9:28am
tags:
Novartis, Pharma CEOs, Joe Jimenez, M&A, animal health, Eli Lilly, GSK, vaccines
Pfizer Announces Positive Top-Line Results from Two Phase 3 Trials of Tofacitinib in Adults with Moderate-to-Severe Chronic Plaque Psoriasis
Yahoo
Tuesday, April 22, 2014 - 9:25am
tags:
Pfizer, chronic plaque psoriasis, tofacitinib
AstraZeneca Plc’s 2 Greatest Weaknesses
Motley Fool
Tuesday, April 22, 2014 - 7:59am
tags:
AstraZeneca
AstraZeneca Rises on Reported Talks With Pfizer Over Deal
Bloomberg
Tuesday, April 22, 2014 - 7:43am
tags:
Pfizer, AstraZeneca, M&A
Novartis Buys Glaxo Cancer Unit for $16B, Sells Animal Health to Eli Lilly for $5.4B
Yahoo/Bloomberg
Tuesday, April 22, 2014 - 7:32am
tags:
Novartis, Joe Jimenez, GSK, animal health, Eli Lilly, vaccines, M&A
Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan
Forbes
Monday, April 21, 2014 - 5:03pm
tags:
Valeant Pharmaceuticals, M&A, Allergan
Pfizer agrees to $190 mln settlement over generic Neurontin
Yahoo/Reuters
Monday, April 21, 2014 - 4:59pm
tags:
Pfizer, generics, Neurontin, epilepsy
Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA
Bloomberg
Monday, April 21, 2014 - 4:58pm
tags:
Eli Lilly, gastric cancer, FDA, ramucirumab
New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy
Seeking Alpha
Monday, April 21, 2014 - 4:51pm
tags:
GSK, diabetes, Tanzeum
What a Combined Pfizer and AstraZeneca Would Look Like, and Face
24/7WallStreet
Monday, April 21, 2014 - 4:48pm
tags:
Pfizer, M&A, AstraZeneca
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Monday, April 21, 2014 - 4:46pm
tags:
Taxotere, Rexahn, RX-21101, patents, patent cliff, Bristol-Myers Squibb, Roche, Sanofi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.